FDG PET scan of the body, frontal view, showing cancer of the lumbar vertebrae, osseous (bony) metastases from prostate cancer in a 65 year old man. FDG (F-labeled 2-deoxyglucose) is a radiopharmaceutical used to differentiate between benign and cancerous tumors by reflecting glucose uptake. (c) Sovereign
Dimensions
2835 x 4252 pixels
Print Size @ 300 dpi
9 x 14 inches / 24 x 36 cm